乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Meeting Coverage >

ISC

<乌鸦传媒>BEST-II Throws Cold Water on Already-Tepid BP Lowering After Stroke Thrombectomy

Trial did not show definite harm, but benefit is unlikely

<乌鸦传媒>Lessons From Flint, Mich. on Stroke Preparedness and Lytic Uptake

Racial disparities narrowed as a result of hospital and community intervention

<乌鸦传媒>Does All Afib Detected After Stroke Really Have to Trigger Oral Anticoagulation?

Stroke neurologists debate skipping secondary prevention anticoagulants for some

<乌鸦传媒>Suboptimal Sleep Duration Linked to Poor Brain Health

Middle-age patients with worse sleep saw increased white matter hyperintensities on MRI

<乌鸦传媒>Tenecteplase on Par With Alteplase, Randomized Trial Affirms

Data from China strengthen the evidence base for off-label use

<乌鸦传媒>Familiar Drugs Get a Foot in the Door for Small Vessel Stroke Treatment

Combined isosorbide mononitrate and cilostazol feasible, well tolerated in these patients

<乌鸦传媒>DAPT Underused for Minor Stroke, TIA

Registry suggests undertreatment, particularly of women and healthier individuals

<乌鸦传媒>Stroke Neuroprotection Drug Passes Early-Phase Hurdle

Infusion before mechanical thrombectomy reduced important outcomes in small phase I/II trial

<乌鸦传媒>Does the Environment Override Genes for People at Risk of Stroke?

Large study detects interaction between genetic susceptibility and neighborhood deprivation

<乌鸦传媒>Cardiac Monitoring Continues to Flag Unsuspected Afib in Broader Population

STROKE AF studied a group not typically considered for Afib detection and management

<乌鸦传媒>Certification Status Makes a Difference for Stroke Centers

Lower-level hospitals performing a "surprising" number of thrombectomies

<乌鸦传媒>Evidence for Stroke Thrombectomy in Kids 'as Good as It Gets'

Expansion of EVT bolstered by population-based study from Australia

<乌鸦传媒>Stroke Clot Composition Linked to Functional Outcomes, Death

Study hints at personalized treatment potential

<乌鸦传媒>DOACs Working Out for CVT Strokes So Far

Findings of ACTION-CVT provide some reassurance

<乌鸦传媒>Lytic Post-Thrombectomy Improved Stroke Outcomes

But a number of problems with clinical trial may require a redo

<乌鸦传媒>Can Tenecteplase Help Late-Presenting Strokes?

Early phase data from China suggestive of benefit

<乌鸦传媒>Tirofiban: A Questionable Addition to Stroke Thrombectomy

Glycoprotein IIb/IIIa receptor inhibitor does show promise for one subgroup in randomized trial

<乌鸦传媒>Intensive Dental Care on Shaky Footing for Cardiovascular Prevention

Stroke survivors fared similarly with regular treatment for gum disease

<乌鸦传媒>Emergent Stroke Care Within Reach for Nearly All in U.S.

Next question is staffing at those centers

<乌鸦传媒>Thrombectomy Helps Large Core Strokes

Randomized trial shows "surprising" magnitude of benefit on par with that in smaller infarcts

<乌鸦传媒>Positive Data Salvaged for Thrombectomy on Basilar Strokes

BEST, BASICS trials not wholly negative, group finds

<乌鸦传媒>COVID Strokes: Rates, Types, Disparities

The latest stroke data from the pandemic illuminates patterns

<乌鸦传媒>Stroke Thrombectomy: 6-Hour Threshold Not So Relevant?

Pooled trial analysis supports move to imaging-based criteria

<乌鸦传媒>Stroke Care: Some Progress on Racial Disparities

But substantial gaps remain

<乌鸦传媒>Adjustable Stent Retriever Passes Muster

Novel device offers better grip on clots in LVO strokes

<乌鸦传媒>Novel Vasoregulator Explored for Acute Ischemic Strokes

Early results may signal benefit for those not treated with thrombectomy

<乌鸦传媒>Loop Recorder Proves Mettle in Broader Stroke Population

STROKE AF trial supports use outside of cryptogenic stroke category

<乌鸦传媒>Don't Ditch the tPA in Stroke Thrombectomy Yet

Direct endovascular therapy dealt a blow in MR CLEAN-NO IV

<乌鸦传媒>Time to Stop Routine Anesthesia for Stroke Thrombectomy?

Neurologists debate pandemic-related guidelines

<乌鸦传媒>Immediate Angiography Feasible for Large Vessel Stroke Patients

Not stopping patients in the ED improved hospital workflow and patient outcomes

<乌鸦传媒>Multi-City Study Bolsters Case for Mobile Stroke Units

But reimbursement woes, balkanized EMS agencies block path to broader use

<乌鸦传媒>Off-Label Alternative to Alteplase Superior for Routine Stroke Thrombolysis?

U.S. center reports favorable experience with arguably better lytic drug

<乌鸦传媒>Lytic Still Needed for Endovascular Stroke Tx

First RCT not definitive but misses non-inferiority

<乌鸦传媒>Mobile Stroke Unit Availability Improves Stroke Clinical Outcomes

Berlin's experience with the world's first units shows the payoff

<乌鸦传媒>Hopes for Novel Stroke Drug Dashed in Trial

But ESCAPE-NA1 signals neuroprotectant might work if given without thrombolytic

<乌鸦传媒>Out of the Basement: Early Results Promising for Portable MRI

Feasibility study indicates no interference in ICU, no metal issues

<乌鸦传媒>Game-Based Stroke Rehab From Home On Par with Clinic

Arm motor function recovery was noninferior in randomized trial

<乌鸦传媒>Lytics Help Imaging-Selected Patients Beyond 4.5-Hour Window

EXTEND trial shows less disability after use in 4.5-to-9-hour window

<乌鸦传媒>Andexanet Holds Strong as Antidote to Apixaban, Rivaroxaban

Reversal agent for factor Xa inhibitors soon to be subject to a randomized trial

<乌鸦传媒>Benefit of Endovascular Therapy Dwindles With Large-Core Strokes

But is thrombectomy still better than medical management alone for these cases?

1